We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Applied Sciences

Applied Sciences

Stay up to date on the topics that matter to you

Laura Elizabeth Lansdowne profile page

Managing Editor

at Technology Networks

As managing editor, Laura works with the editorial director to create, inform and maintain the overall editorial strategy for Technology Networks. She oversees the in-house editorial team and works directly with commissioned writers to produce content across the publication’s communities. After obtaining a first-class honors degree in biology, Laura worked as a quality assurance technologist before joining the Wellcome Sanger Institute and undertaking an additional qualification in clinical chemistry. In 2015, she left to pursue pharmaceutical and editorial-based roles, before joining Technology Networks in 2017.

Education

University of Kent

Nottingham Trent University

Writtle University College

Chartered Institute of Editing and Proofreading

Accreditations

Biology, BSc (Hons) recognised by The University of Kent

Areas of Expertise

Drug Screening Strategies

Pharmaceutical Development

Molecular & Cellular Biology

Got a Question for Laura Elizabeth Lansdowne?

Get in touch using the contact form linked here and we'll get back to you shortly.

Published Content

Total: 410

Developing Temperature-Stable ADDomer Vaccines for Untreatable Diseases content piece image

Industry Insight

Developing Temperature-Stable ADDomer Vaccines for Untreatable Diseases

Technology Networks spoke with Jonathan Hare, PhD, Imophoron’s Head of Immunology, to learn more about the ADDomer™ vaccine platform, the benefits of administering vaccines by a variety of administrative routes and the infectious diseases they are currently working to develop vaccines for.

Recent Developments in Proteomics Research content piece image

Recent Developments in Proteomics Research

Here, we take a closer look at some recent developments in the world of proteomics research.

Opinionated Science Episode 39: The Science of Christmas Dinner content piece image

Opinionated Science Episode 39: The Science of Christmas Dinner

In this bumper episode, the team review a series of studies from the last year that investigate Christmassy food. Could the future of Christmas dinner involve a cell culture roast, unnaturally smooth chocolate and fractal cauliflower?

Cancer Epigenetics content piece image

Cancer Epigenetics

Today, there is growing evidence that in various diseases, including different types of cancer, there are underlying epigenetic mechanisms at play. Download this infographic to explore various epigenetic mechanisms in cancer.

New Non-Lethal Method To Study Scorpion Venom content piece image

New Non-Lethal Method To Study Scorpion Venom

Researchers have discovered a non-lethal way to study scorpion venom genes by triggering the emptying of the animal’s venom glands using electrostimulation. The study was published in PLOS ONE.

Team Reverses the Clinical Signs of Alzheimer’s Disease in Mice content piece image

Team Reverses the Clinical Signs of Alzheimer’s Disease in Mice

In a study published in Genome Medicine, Dr. Patrick Aloy, head of the structural bioinformatics and network biology laboratory at IRB Barcelona and colleagues report that they have successfully reversed the clinical signs of Alzheimer's disease in mice by repurposing four existing drugs that are currently approved to treat high blood pressure and inflammation.

Identifying Novel Drug Targets for Neurodegeneration content piece image

Identifying Novel Drug Targets for Neurodegeneration

During this year’s ELRIG Drug Discovery Meeting, Prof. Paul Brennan from the University of Oxford, discussed recent progress to develop drug compounds against novel targets in neuroinflammatory and sub-cellular organelle dysfunction pathways.

Opinionated Science Episode 37: Finding Answers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Mesothelioma content piece image

Opinionated Science Episode 37: Finding Answers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Mesothelioma

In this podcast, the team look at two overlooked diseases. Malignant mesothelioma was known to be caused by the construction material asbestos decades before it was banned, while ME/CFS remains poorly understood by science. Two new developments could bring and clarity and a route to better treatment for these conditions.

The Role of Neuropilin-1 in SARS-CoV-2 Infection content piece image

The Role of Neuropilin-1 in SARS-CoV-2 Infection

Dr. Maria Anastasina from the University of Helsinki and colleagues have been investigating the involvement of neuropilin-1 in SARS-CoV-2 cell entry and infectivity. Technology Networks had the pleasure of speaking with Anastasina to learn more about this work.

Reconnecting at ELRIG Drug Discovery 2021 content piece image

Reconnecting at ELRIG Drug Discovery 2021

Technology Networks is delighted to be reporting – in person – from The European Laboratory Research & Innovation Group (ELRIG)'s Drug Discovery 2021 meeting. In this article, we explore the key themes discussed in the meeting's opening address.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter